Clinical trial
Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and…
NCT00232882 · Institut de Recherches Cliniques de Montreal, Other · Completed
Key facts
| NCT number | NCT00232882 |
|---|---|
| Title | Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. |
| Official title | Neurohumoral and Oxidative Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Essential Hypertensive Patients. |
| Lead sponsor | Institut de Recherches Cliniques de Montreal, Other |
| Collaborators | Ottawa Hospital Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Candesartan Thiazide, Atenolol Thiazide, Thiazide Candesartan |
| Enrollment | 86 |
| Start date | Dec 1, 2003 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Oct 5, 2005 |
| Last update posted | Sep 4, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: